Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Molecular Pharmacology
|
June 20, 1998
Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis
A Jagerschmidt, N Guillaume, B P Roques, et al.
Journal of Neurochemistry
|
October 1, 1994
Identification and characterization of various cholecystokinin B receptor mRNA forms in rat brain tissue and partial determination of the cholecystokinin B receptor gene structure
A Jagerschmidt, T Popovici, M O'Donohue, et al.
Molecular Pharmacology
|
November 1, 1995
Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction
A Jagerschmidt, N Guillaume, N Goudreau, et al.
The Biochemical Journal
|
July 25, 1998
Human thrombopoietin structure-function relationships: identification of functionally important residues
A Jagerschmidt, V Fleury, M Anger-Leroy, et al.
European Journal of Pharmacology
|
January 18, 1996
His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity
A Jagerschmidt, N Guillaume-Rousselet, M L Vikland, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Molecular Pharmacology
|
June 20, 1998
Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis
A Jagerschmidt, N Guillaume, B P Roques, et al.
Journal of Neurochemistry
|
October 1, 1994
Identification and characterization of various cholecystokinin B receptor mRNA forms in rat brain tissue and partial determination of the cholecystokinin B receptor gene structure
A Jagerschmidt, T Popovici, M O'Donohue, et al.
Molecular Pharmacology
|
November 1, 1995
Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction
A Jagerschmidt, N Guillaume, N Goudreau, et al.
The Biochemical Journal
|
July 25, 1998
Human thrombopoietin structure-function relationships: identification of functionally important residues
A Jagerschmidt, V Fleury, M Anger-Leroy, et al.
European Journal of Pharmacology
|
January 18, 1996
His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity
A Jagerschmidt, N Guillaume-Rousselet, M L Vikland, et al.
Page
of 1